MFDS — authorised 23 February 2000
- Marketing authorisation holder: ALCON PHARMS LTD
- Status: likely_approved
🇰🇷 Betaxon in South Korea
MFDS authorised Betaxon on 23 February 2000
Marketing authorisation
Betaxon in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in South Korea
Frequently asked questions
Is Betaxon approved in South Korea?
Yes. MFDS authorised it on 23 February 2000.
Who is the marketing authorisation holder for Betaxon in South Korea?
ALCON PHARMS LTD holds the South Korean marketing authorisation.